Literature DB >> 1360476

Epidemiology of nosocomial acquisition of Candida lusitaniae.

V Sanchez1, J A Vazquez, D Barth-Jones, L Dembry, J D Sobel, M J Zervos.   

Abstract

Candida species are important nosocomial pathogens; however, little is known about the epidemiology of Candida lusitaniae, an organism frequently resistant to amphotericin B. We evaluated 98 patients admitted to the bone marrow transplant and medical intensive care units of a tertiary-care hospital. Each patient with C. lusitaniae was matched with control patients. Restriction fragment analysis of DNA was used to determine strain relatedness. Seven patients (7.1%) with C. lusitaniae were identified; five acquired C. lusitaniae after admission to the study unit. All isolates were susceptible to amphotericin B. There were no differences between patients and controls with regard to duration of stay in the study unit, antibiotic administration, antifungal therapy, immunosuppressive therapy, catheter use, or underlying disease. Temporal and geographic clustering of five patients with identical strains occurred. No common source was identified. Restriction fragment analysis revealed a total of eight strains, and five patients shared one strain type. These results demonstrate exogenous acquisition of C. lusitaniae. The mechanism of acquisition is probably indirect contact transmission between patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360476      PMCID: PMC270571          DOI: 10.1128/jcm.30.11.3005-3008.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Comparison of restriction enzyme analysis and pulsed-field gradient gel electrophoresis as typing systems for Candida albicans.

Authors:  J A Vazquez; A Beckley; J D Sobel; M J Zervos
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

2.  Applied molecular genetics: new tools for microbiologists and clinicians.

Authors:  B I Eisenstein; N C Engleberg
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

3.  High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection.

Authors:  M J Zervos; S Dembinski; T Mikesell; D R Schaberg
Journal:  J Infect Dis       Date:  1986-06       Impact factor: 5.226

4.  Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts.

Authors:  R A Cook; K A McIntyre; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

5.  Transient fungemia due to Candida lusitaniae.

Authors:  R W Bradsher; F J White
Journal:  South Med J       Date:  1985-05       Impact factor: 0.954

6.  In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.

Authors:  D G Ahearn; M S McGlohn
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

7.  Identification of Candida lusitaniae as an opportunistic yeast in humans.

Authors:  D L Holzschu; H L Presley; M Miranda; H J Phaff
Journal:  J Clin Microbiol       Date:  1979-08       Impact factor: 5.948

8.  Isolation and characterization of a polyene-resistant variant of Candida tropicalis.

Authors:  W G Merz; G R Sandford
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

9.  Use of agarose gel electrophoresis of plasmid deoxyribonucleic acid to fingerprint gram-negative bacilli.

Authors:  D R Schaberg; L S Tompkins; S Falkow
Journal:  J Clin Microbiol       Date:  1981-06       Impact factor: 5.948

10.  Outbreak of systemic Candida albicans in intensive care unit caused by cross infection.

Authors:  J P Burnie; F C Odds; W Lee; C Webster; J D Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-09
View more
  25 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Emerging Issues in Nosocomial Fungal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

3.  The microbial colonization profile of respiratory devices and the significance of the role of disinfection: a blinded study.

Authors:  Savita Jadhav; Tushar Sahasrabudhe; Vipul Kalley; Nageswari Gandham
Journal:  J Clin Diagn Res       Date:  2013-05-11

4.  Nosocomial Candida glabrata colonization: an epidemiologic study.

Authors:  J A Vazquez; L M Dembry; V Sanchez; M A Vazquez; J D Sobel; C Dmuchowski; M J Zervos
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy.

Authors:  Sandra A Asner; Stefano Giulieri; Manuel Diezi; Oscar Marchetti; Dominique Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

6.  Alternative identification test relying upon sexual reproductive abilities of Candida lusitaniae strains isolated from hospitalized patients.

Authors:  F François; T Noël; R Pépin; A Brulfert; C Chastin; A Favel; J Villard
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

7.  Epidemiology of nosocomial fungal infections.

Authors:  S K Fridkin; W R Jarvis
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

8.  In vitro activity of a new pneumocandin antifungal agent, L-733,560 against azole-susceptible and -resistant Candida and Torulopsis species.

Authors:  J A Vazquez; M Lynch; J D Sobel
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

9.  Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models.

Authors:  D J Austin; R M Anderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

Review 10.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.